Santiago Vasquez, General Director for Ecuador’s National Service for Public Contracts (Sercop), joined his counterpart at the country’s competition and markets regulator, SCPM, Cristian Ruiz, in presenting a series of initiatives set in motion by their respective agencies in order to improve the process of public bidding, to encourage greater transparency and promote open and ethical competition between state suppliers.
In this vein, the Sercop Director had publicly requested Mr. Ruiz to instruct the SCPM to analyze the actions of several companies which recently participated in a Reverse Bidding for Corporate Medicine. Mr. Ruiz in turn handed over documentation on a number of antitrust and competition violations detected among a number of pharmaceutical companies.
Mr. Vasquez pointed out that both institutions have coordinated their actions from the start of the Reverse Bidding process, carrying out preemptive actions to protect the wellbeing of Ecuador’s citizens and their right to decent healthcare and access to quality medication.
Full Content: El Telegrafo
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Big Tech Braces for Potential Changes Under a Second Trump Presidency
Nov 6, 2024 by
CPI
Trump’s Potential Shift in US Antitrust Policy Raises Questions for Big Tech and Mergers
Nov 6, 2024 by
CPI
EU Set to Fine Apple in First Major Enforcement of Digital Markets Act
Nov 5, 2024 by
CPI
Six Indicted in Federal Bid-Rigging Schemes Involving Government IT Contracts
Nov 5, 2024 by
CPI
Ireland Secures First €3 Billion Apple Tax Payment, Boosting Exchequer Funds
Nov 5, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Remedies Revisited
Oct 30, 2024 by
CPI
Fixing the Fix: Updating Policy on Merger Remedies
Oct 30, 2024 by
CPI
Methodology Matters: The 2017 FTC Remedies Study
Oct 30, 2024 by
CPI
U.S. v. AT&T: Five Lessons for Vertical Merger Enforcement
Oct 30, 2024 by
CPI
The Search for Antitrust Remedies in Tech Leads Beyond Antitrust
Oct 30, 2024 by
CPI